Фармакоинвазивная реперфузионная терапия у больных с острым инфарктом миокарда с подъемом сегмента ST


Full text:  

 

References

1. Keeley C., Boura J. A., Grines C. L. Primary angioplasty versus intravenous thrombolytic therapy for acute myocardial infarction: a quantitative review of 23 randomised trials // Lancet. - 2003. - Vol. 361. - P. 13-20.
2. Stenestrand U., Wallentin L. Early revascularisation and 1-year survival in 14-day survivors of acute myocardial infarction: a prospective cohort study // Ibid. - 2002. - Vol. 359. - P. 1805-1811.
3. Nallamothu B. K., Bates E. R., Herrin J. et al. Times to treatment in transfer patients undergoing primary percutaneous coronary intervention in the United States: National Registry of Myocardial Infarction (NRMI)-3/4 analysis // Circulation. - 2005. - Vol. 111. - P. 761-767.
4. Eagle K. A., Goodman Sh. G., Avezum A. et al. Practice variation and missed opportunities for reperfusion in ST segment-elevation myocardial infarction: findings from the Global Registry of Acute Coronary Events (GRACE) // Lancet. - 2002. - Vol. 359. - P. 373-377.
5. Collet J. P., Montalescot G., Le May M. et al. Percutaneous corona intervention after fibrinolysis: a multiple meta-analyses approach according to the type of strategy // J. Amer. Coll. Cardiol. - 2006. - Vol. 48. - P. 1326-1335.
6. Keeley E. C., Boura J. A., Grines C. L. Comparison of primary and facilitated percutaneous coronary interventions for ST-elevation myocardial infarction: quantitative review of randomised trials // Lancet. - 2006. - Vol. 367. - P. 579-588.
7. Assessment of the Safety and Efficacy of a New Treatment Strategy with Percutaneous Coronary Intervention (ASSENT-4 PCI) investigators. Primary versus tenecteplase - facilitated percutaneous coronary intervention in patients with STsegment elevation acute myocardial infarction (ASSENT-4 PCI): randomised trial // Ibid. - 2006. - Vol. 367. - P. 569-578.
8. Hospital Statistics / American Hospital Association. - Chicago (Ill): Health Forum LLC, 2004.
9. Kawano K., Aoki I., Aoki N. et al. Human platelet activation by thrombolytic agents: effects of tissuetype plasminogen activator and urokinase on platelet surface P - selectin expression // Amer. Heart J. - 1998. - Vol. 135. - P. 268-271.
10. Aviles F. Grupo de Analisis de la Cardiopata Isquemica Aguda (GRACIA-2). European Congress of Cardiology. Vienna, 2003.
11. Kastrati, Mehilli J., Schuhien H. et al. A clinical trial of abciximab in elective percutaneous coronary intervention after pretreatment with clopidogrel // N. Engl. J. Med. - 2004. - Vol. 350. - P. 232-238.
12. Widimsky P., Budesinsky T., Vorac D. et al. Long distance transport for primary angioplasty vs immediate thrombolysis in acute myocardial infarction. Final results of the randomized national multicentre trial - PRAGUE-2 // Eur. Heart J. - 2003. - Vol. 24. - P. 94-104.
13. Bonnefoy E., Lapostolle F., Leizorovicz A. et al. On behalf of the Comparison of Angioplasty, Prehospital Thrombolysis in Acute Myocardial Infarction (CAPTIM) study group. Primary angioplasty versus prehospital fibrinolysis in acute myocardial infarction: a randomised study // Lancet. - 2002. - Vol. 360. - P. 825-829.
14. Kalla K., Christ G., Karnik R. et al. Implementation of guidelines improves the standard of care: the Viennese Registry on Reperfusion Strategies in ST-Elevation Myocardial Infarction (Vienna STEMI registry) // Circulation. - 2006. - Vol. 113. - P. 2398-2405.

Chief Editor

Leo A. Bockeria, MD, PhD, DSc, Professor, Academician of Russian Academy of Sciences, President of Bakoulev National Medical Research Center for Cardiovascular Surgery